Last reviewed: June 24, 2026
Last updated: June 24, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Wegovy (semaglutide injection) is a branded GLP-1 medication approved by the FDA for chronic weight management, but it's not the only option delivering clinically meaningful results. PlexusDx offers compounded semaglutide and tirzepatide injections from licensed 503A pharmacies that provide comparable mechanisms of action at different price points and accessibility levels for all 50 states.
How Compounded Semaglutide Compares to Branded Wegovy
Wegovy and compounded semaglutide contain the same active pharmaceutical ingredient—semaglutide—a GLP-1 receptor agonist that slows gastric emptying and increases feelings of fullness. Both medications work through identical biological pathways, targeting the same brain centers that regulate appetite and blood sugar. The primary differences are manufacturing location, distribution channels, and cost structure rather than clinical efficacy.
Clinical trials supporting semaglutide show an average weight loss of 10–15% of body weight over 68 weeks at therapeutic doses, with some patients achieving up to 22% reductions. Compounded semaglutide from PlexusDx's licensed pharmacies meets the same pharmaceutical standards and potency requirements as branded formulations, ensuring patients receive the dose strength prescribed. PlexusDx compounded semaglutide injection starts at $149 per month, making it accessible without insurance coverage or membership fees.
Tirzepatide as a Dual-Action Alternative to GLP-1 Only
Tirzepatide (brand name Zepbound) represents a newer category called GIP/GLP-1 receptor agonists, activating two hormone pathways instead of one. This dual mechanism may produce greater weight loss than GLP-1-only medications in some patients, with clinical trials showing reductions of 20–22% over 72 weeks at maximum doses. PlexusDx offers compounded tirzepatide injection starting at $249 per month, providing access to this more powerful option without insurance requirements.
Patients who plateau on semaglutide alone sometimes benefit from switching to tirzepatide, as the additional GIP pathway may reignite weight loss response. Response varies by individual genetic predispositions—PlexusDx's Precision Peptide Genetic Test identifies variants in GIPR and GLP1R genes that predict which medication class may work best for each patient's biology.
Oral vs. Injection: Flexible Delivery Options
Not all patients prefer injections, and PlexusDx addresses this with oral formulations of both semaglutide and tirzepatide. Oral semaglutide starts at $249 per month, while oral tirzepatide begins at $279 per month. Oral versions offer convenience for patients who travel frequently or dislike needles, though injectable forms typically reach therapeutic levels faster and may require lower total doses.
Clinical absorption of oral GLP-1 compounds is lower than injected versions, so oral semaglutide often requires higher pill doses to match injection potency. PlexusDx tailors medication selection based on patient preference, lifestyle, and genetic markers that influence how quickly the body processes peptide medications.
Cost Savings and Accessibility Without Insurance
Branded Wegovy typically costs $935–$1,350 per month with insurance copays, and uninsured patients may pay the full retail price of $1,500 or more. PlexusDx compounded semaglutide at $149 per month represents an 80–90% savings for patients with consistent dosing needs. Your dose may need to go up as treatment progresses, but your monthly price won't—PlexusDx maintains flat monthly pricing across all dose levels.
HSA and FSA accounts are accepted by PlexusDx, allowing tax-advantaged spending on weight loss medications. Patients in all 50 states can access treatment without membership fees, prior insurance denials, or complex authorization processes. The Precision Peptide Genetic Test ($99 add-on after the first month) helps identify which medication delivers the best metabolic response for your unique genetic profile, potentially reducing waste on ineffective trials.
Choosing Between Semaglutide, Tirzepatide, and Combination Protocols
Most patients begin with compounded semaglutide because it's well-studied, tolerable, and cost-effective. Those seeking faster results or who have plateaued may escalate to tirzepatide or try PlexusDx's GLP-Squared formulations—dual-compound injections combining semaglutide and tirzepatide at higher total peptide concentration. GLP-Squared injection starts at $249 per month, while GLP-Squared oral begins at $369 per month.
The Microdose GLP-1 Protocol ($129 per month flat) serves patients new to peptide therapy or those seeking gentler initial titration to minimize side effects. All PlexusDx medications originate from licensed 503A compounding pharmacies that adhere to strict pharmaceutical standards, quality assurance, and sterility protocols identical to FDA-regulated manufacturers.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is compounded semaglutide as effective as brand-name Wegovy?
Compounded semaglutide contains the identical active ingredient as Wegovy and activates the same GLP-1 receptor pathways. Clinical efficacy depends on dose, consistency, patient adherence, and individual metabolism rather than brand origin. PlexusDx compounds from licensed 503A pharmacies meet pharmaceutical potency and purity standards equivalent to branded formulations.
How much weight can I expect to lose with PlexusDx semaglutide or tirzepatide?
Clinical trials show semaglutide produces average weight loss of 10–15% of body weight, while tirzepatide achieves 20–22% reductions over similar timeframes. Individual results vary based on genetics, diet, activity level, medication adherence, and metabolic rate. PlexusDx's Precision Peptide Genetic Test can identify genetic factors predicting your likely response to each medication.
Why is PlexusDx compounded medication cheaper than Wegovy?
Wegovy includes brand premium, extensive marketing costs, and a branded pharmacy distribution network. PlexusDx eliminates middleman markups by sourcing directly from licensed 503A compounding pharmacies and operates without membership or subscription fees. Compounded medications cost less to produce while maintaining identical pharmaceutical standards—savings pass directly to patients.
Are there side effects with compounded semaglutide or tirzepatide?
Both medications can cause nausea, vomiting, constipation, and fatigue—especially during dose escalation. These effects typically diminish within 1–2 weeks as the body adjusts. Serious side effects are rare but include pancreatitis or thyroid concerns; patients with personal or family thyroid cancer history should consult their doctor before starting. PlexusDx requires a health questionnaire and physician consultation to screen for contraindications.
How does the Precision Peptide Genetic Test help me choose between medications?
PlexusDx's genetic test analyzes variants in GIPR, GLP1R, FTO, and MC4R genes that influence how your body responds to GLP-1 and GIP receptor activation. These insights map 14 metabolic pathways and 49 peptides, predicting whether you'll respond best to semaglutide, tirzepatide, combination therapy, or microdose protocols. The test costs $99 as an add-on after your first month of treatment.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
When Does Ozempic Start Working After Injection?
How to Not Gain Weight After Stopping Zepbound